Maintenance of Skin Clearance With Ixekizumab Treatment of Psoriasis: Three-Year Results From the UNCOVER-3 Study

Ixekizumab treatment is associated with a high level of skin clearance in patients with psoriasis., After 3 years of ixekizumab treatment, a majority of patients sustained a PASI 90 response, with no new safety signals.. Ixekizumab is a reasonable long-term treatment option for patients with moderate-to-severe plaque psoriasis.

https://ift.tt/2kmfXRK